Naseem A. Jaffrani
Expertise in
42
conditions

Dr. Naseem A. Jaffrani

Cardiology
2108 Texas Ave., Suite 3080, Suite 3080, 
Alexandria, LA 
Accepting New Patients
Referral may be required
Before you request
Expertise in
42
conditions
2108 Texas Ave., Suite 3080, Suite 3080, 
Alexandria, LA 

Overview

Naseem Jaffrani is a Cardiologist practicing medicine in Alexandria, Louisiana.

Dr. Jaffrani is highly rated in 42 conditions, according to our data. His clinical expertise encompasses Angina, Metabolic Syndrome, Atherosclerosis, Heart Bypass Surgery, and Cardiac Ablation.

Dr. Jaffrani is board certified in American Board Of Internal Medicine. He is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 7 clinical trials. Dr. Jaffrani is currently accepting new patients.

Specialties

Cardiology

Licenses

Internal Medicine in LA

Board Certifications

American Board Of Internal Medicine

Fellowships

Chicago Medical School at Rosalind Franklin University of Medicine & Science

Hospital Affiliations

CHRISTUS Health Plan
CHRISTUS St. Frances Cabrini Hospital
CHRISTUS Trinity Clinic
CHRISTUS Trinity Clinic Texas
Christus St Frances Cabrini Hospital
Riverland Medical Center
Natchitoches Regional Medical Center
Hardtner Medical Center
Lasalle General Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Louisiana Healthcare Connections
  • HMO
  • MANAGED MEDICAID PLAN
Magnolia Health
  • HMO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

Heart & Vascular Institute
2108 Texas Ave., Suite 3080, Suite 3080, Alexandria, LA 71301
Other Locations
St. Frances Cabrini
3330 Masonic Dr., Alexandria, LA 71301

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With Established Cardiovascular Disease
A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With Established Cardiovascular Disease
Enrollment Status: Completed
Publish Date: August 28, 2026
Intervention Type: Drug
Study Drug: TQJ230
Study Phase: Phase 3
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: July 08, 2026
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3
RESOLUTION: A Double-blind, Randomized, Placebo-controlled, Phase II/III Study of the Efficacy and Safety of LAU-7b in the Treatment of Adult Hospitalized Patients With COVID-19 Disease
RESOLUTION: A Double-blind, Randomized, Placebo-controlled, Phase II/III Study of the Efficacy and Safety of LAU-7b in the Treatment of Adult Hospitalized Patients With COVID-19 Disease
Enrollment Status: Terminated
Publish Date: November 13, 2025
Intervention Type: Drug
Study Drug: Fenretinide
Study Phase: Phase 2/Phase 3
A Randomized, Double-Blind, Placebo- Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure With Iron Deficiency /and Sub-Study
A Randomized, Double-Blind, Placebo- Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure With Iron Deficiency /and Sub-Study
Enrollment Status: Completed
Publish Date: July 03, 2024
Intervention Type: Drug
Study Drug: Ferric Carboxymaltose
Study Phase: Phase 3
A Phase 2, Open Label, Randomized Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) With Standard of Care Versus Standard of Care in Subjects Hospitalized With COVID-19
A Phase 2, Open Label, Randomized Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) With Standard of Care Versus Standard of Care in Subjects Hospitalized With COVID-19
Enrollment Status: Completed
Publish Date: January 18, 2023
Intervention Type: Drug, Other
Study Drug: Abivertinib
Study Phase: Phase 2
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure (CONNECT-HF)
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure (CONNECT-HF)
Enrollment Status: Completed
Publish Date: January 25, 2021
Intervention Type: Other
Study Phase: Not Applicable
Phase 2B Double-blind Placebo-controlled Efficacy Trial of EVO100 (Previously Known as Amphora ® Gel) for the Prevention of Acquisition of Urogenital Chlamydia Trachomatis Infection
Phase 2B Double-blind Placebo-controlled Efficacy Trial of EVO100 (Previously Known as Amphora ® Gel) for the Prevention of Acquisition of Urogenital Chlamydia Trachomatis Infection
Enrollment Status: Completed
Publish Date: August 12, 2020
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
View 6 Less Clinical Trials

2 Total Publications

An "Inclisiran First" Strategy vs Usual Care in Patients With Atherosclerotic Cardiovascular Disease.
An "Inclisiran First" Strategy vs Usual Care in Patients With Atherosclerotic Cardiovascular Disease.
Journal: Journal of the American College of Cardiology
Published: February 22, 2024
Similar Doctors
Expertise in
55
conditions
Dr. Harry R. Hawthorne
Cardiology | Cardiac Electrophysiology
Expertise in
55
conditions
Dr. Harry R. Hawthorne
Cardiology | Cardiac Electrophysiology
Referral required
Before you request

CHRISTUS Trinity Clinic

2108 Texas Avenue, Suite 3062, 
Alexandria, LA 
 (0.1 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Harry Hawthorne is a Cardiologist and a Cardiac Electrophysiologist practicing medicine in Alexandria, Louisiana. Dr. Hawthorne is highly rated in 55 conditions, according to our data. His clinical expertise encompasses Arrhythmias, Sick Sinus Syndrome, Atrial Fibrillation, Pacemaker Implantation, and Cardiac Ablation. Dr. Hawthorne is currently accepting new patients.

Expertise in
45
conditions
Expertise in
45
conditions
Referral may be required

CHRISTUS Community Clinic

3351 Masonic Dr, 
Alexandria,, LA 
 (0.2 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Vikram Nijjar is a Cardiologist practicing medicine in Alexandria,, Louisiana. Dr. Nijjar is highly rated in 45 conditions, according to our data. His clinical expertise encompasses Coronary Heart Disease, Atherosclerosis, Angina, Thrombectomy, and Pacemaker Implantation. Dr. Nijjar is currently accepting new patients.

Expertise in
34
conditions
Expertise in
34
conditions
Referral may be required

Rapides Heart And Vascular Specialists - Suite 2D

201 4th St Ste 2D, 
Alexandria, LA 
 (0.8 miles away)
Experience:
44+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Arun Karsan is a Cardiologist practicing medicine in Alexandria, Louisiana. He has been practicing medicine for over 44 years. Dr. Karsan is highly rated in 34 conditions, according to our data. His clinical expertise encompasses Hypertension, Glucocorticoid-Remediable Aldosteronism, Angina, Heart Bypass Surgery, and Coronary Artery Bypass Graft (CABG). Dr. Karsan is currently accepting new patients.

Frequently Asked Questions about Dr. Naseem A. Jaffrani

How do I make an appointment with Dr. Naseem A. Jaffrani?

You can book an appointment with Dr. Naseem A. Jaffrani by calling their office at 318-528-4770. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Naseem A. Jaffrani a top-rated expert for Angina?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Naseem A. Jaffrani is classified as an Distinguished expert for Angina, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Naseem A. Jaffrani specialize in?

While Dr. Naseem A. Jaffrani is a Cardiology, they have specific expertise in Angina, Metabolic Syndrome, and Atherosclerosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Cardiology.

Does Dr. Naseem A. Jaffrani participate in research or clinical trials?

Yes. Dr. Naseem A. Jaffrani has published 2 articles and abstracts on conditions like Angina. You can view a list of Dr. Naseem A. Jaffrani's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Naseem A. Jaffrani accept my insurance?

Dr. Naseem A. Jaffrani accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 318-528-4770 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Jaffrani's expertise for a condition
ConditionClose
    View All 10 Distinguished Conditions
    View All 32 Advanced Conditions
    View All 67 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile